These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18721111)

  • 1. In silico prediction of substrate properties for ABC-multidrug transporters.
    Demel MA; Schwaha R; Krämer O; Ettmayer P; Haaksma EE; Ecker GF
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1167-80. PubMed ID: 18721111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting ligand interactions with ABC transporters in ADME.
    Demel MA; Krämer O; Ettmayer P; Haaksma EE; Ecker GF
    Chem Biodivers; 2009 Nov; 6(11):1960-9. PubMed ID: 19937827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.
    Schinkel AH; Jonker JW
    Adv Drug Deliv Rev; 2003 Jan; 55(1):3-29. PubMed ID: 12535572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multispecificity of drug transporters: probing inhibitor selectivity for the human drug efflux transporters ABCB1 and ABCG2.
    Cramer J; Kopp S; Bates SE; Chiba P; Ecker GF
    ChemMedChem; 2007 Dec; 2(12):1783-8. PubMed ID: 17994597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
    Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
    Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.
    Strouse JJ; Ivnitski-Steele I; Waller A; Young SM; Perez D; Evangelisti AM; Ursu O; Bologa CG; Carter MB; Salas VM; Tegos G; Larson RS; Oprea TI; Edwards BS; Sklar LA
    Anal Biochem; 2013 Jun; 437(1):77-87. PubMed ID: 23470221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.
    Daood M; Tsai C; Ahdab-Barmada M; Watchko JF
    Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Karanjin interferes with ABCB1, ABCC1, and ABCG2.
    Michaelis M; Rothweiler F; Nerreter T; Sharifi M; Ghafourian T; Cinatl J
    J Pharm Pharm Sci; 2014; 17(1):92-105. PubMed ID: 24735762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
    Chen Y; Bieber MM; Teng NN
    Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression and functionality of ATP-binding cassette transporters in the human hair follicle.
    Haslam IS; El-Chami C; Faruqi H; Shahmalak A; O'Neill CA; Paus R
    Br J Dermatol; 2015 Jun; 172(6):1562-1572. PubMed ID: 25418064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp.
    Zhang Y; Laterra J; Pomper MG
    Neoplasia; 2009 Jan; 11(1):96-101. PubMed ID: 19107236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
    Shukla S; Robey RW; Bates SE; Ambudkar SV
    Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.
    Haufroid V
    Curr Drug Targets; 2011 May; 12(5):631-46. PubMed ID: 21039333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
    Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
    Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2).
    Ieiri I
    Drug Metab Pharmacokinet; 2012; 27(1):85-105. PubMed ID: 22123128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ABC transporters is an unfavorable prognostic factor in laryngeal squamous cell carcinoma.
    Shen B; Li D; Dong P; Gao S
    Ann Otol Rhinol Laryngol; 2011 Dec; 120(12):820-7. PubMed ID: 22279954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.
    Ji N; Yang Y; Cai CY; Lei ZN; Wang JQ; Gupta P; Shukla S; Ambudkar SV; Kong D; Chen ZS
    Cancer Lett; 2019 Jan; 440-441():82-93. PubMed ID: 30315846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.